United States · FDA National Drug Code directory
Auryxia
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59922-631_79cb63af-94fa-4f49-91d3-543c0058cd4e
- Product NDC
- 59922-631
- Form
- TABLET, FILM COATED
- Composition / generic term
- ferric citrate
- Labeler
- Akebia Therapeutics, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20140917
- Source listing expiry
- 20261231
Source-listed ingredients
- TETRAFERRIC TRICITRATE DECAHYDRATE — 210 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 200 TABLET, FILM COATED in 1 BOTTLE (59922-631-01) · 59922-631-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →